11th October 2017
Nitrous oxide returns to the news, providing an opportunity to discuss its harms and ask quite frankly: why are we wasting money on enforcing the ban when it kills fewer people than lightning strikes?
22nd February 2017
As high-purity/high-dose ecstasy pills return to the market and casualties rise, Oli Stevens discusses the roles testing can play. It can act as a harm reduction initiative, can it shape the composition of drug markets themselves?